Using  	Using  	 VBG	O
Human  	Human  	 NNP	O
Induced  	Induced  	 NNP	B-NP
Pluripotent  	Pluripotent  	 NNP	I-NP
Stem  	Stem  	 NNP	I-NP
Cells  	Cells  	 NNP	I-NP
to  	to  	 TO	O
Model  	Model  	 NNP	B-NP
Skeletal  	Skeletal  	 NNP	I-NP
Diseases  	Diseases  	 NNP	I-NP
Musculoskeletal  	Musculoskeletal  	 NNP	I-NP
disorders  	disorders  	 NNS	I-NP
affecting  	affecting  	 VBG	O
the  	the  	 DT	O
bones  	bones  	 NNS	O
and  	and  	 CC	O
joints  	joints  	 NNS	O
are  	are  	 VBP	O
major  	major  	 JJ	O
health  	health  	 NN	B-NP
problems  	problems  	 NNS	I-NP
among  	among  	 IN	O
children  	children  	 NNS	O
and  	and  	 CC	O
adults 	adults 	 NNS	O
.  	.  	 .	O
Major  	Major  	 JJ	O
challenges  	challenges  	 NNS	O
such  	such  	 JJ	O
as  	as  	 IN	O
the  	the  	 DT	O
genetic  	genetic  	 JJ	B-NP
origins  	origins  	 NNS	I-NP
or  	or  	 CC	O
poor  	poor  	 JJ	O
diagnostics  	diagnostics  	 NNS	O
of  	of  	 IN	O
severe  	severe  	 JJ	O
skeletal  	skeletal  	 JJ	B-NP
disease  	disease  	 NN	I-NP
hinder  	hinder  	 VB	O
our  	our  	 PRP$	O
understanding  	understanding  	 NN	O
of  	of  	 IN	O
human  	human  	 JJ	O
skeletal  	skeletal  	 JJ	B-NP
diseases 	diseases 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
recent  	recent  	 JJ	O
advent  	advent  	 NN	B-NP
of  	of  	 IN	O
human  	human  	 JJ	O
induced  	induced  	 JJ	O
pluripotent  	pluripotent  	 NNS	B-NP
stem  	stem  	 VBP	O
cells  	cells  	 NNS	O
( 	( 	 -LRB-	O
human  	human  	 JJ	O
iPS  	iPS  	 JJ	B-NP
cells 	cells 	 NNS	I-NP
)  	)  	 -RRB-	O
provides  	provides  	 VBZ	O
an  	an  	 DT	O
unparalleled  	unparalleled  	 JJ	O
opportunity  	opportunity  	 NN	O
to  	to  	 TO	O
create  	create  	 VB	O
human-specific  	human-specific  	 JJ	B-NP
models  	models  	 NNS	I-NP
of  	of  	 IN	O
human  	human  	 JJ	O
skeletal  	skeletal  	 NNS	B-NP
diseases.  	diseases.  	 VBP	I-NP
iPS  	iPS  	 JJ	O
cells  	cells  	 NNS	O
have  	have  	 VBP	O
the  	the  	 DT	O
ability  	ability  	 NN	B-NP
to  	to  	 TO	O
self-renew 	self-renew 	 JJ	O
,  	,  	 ,	O
allowing  	allowing  	 VBG	O
us  	us  	 PRP	O
to  	to  	 TO	O
obtain  	obtain  	 VB	O
large  	large  	 JJ	O
amounts  	amounts  	 NNS	O
of  	of  	 IN	O
starting  	starting  	 VBG	B-NP
material 	material 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
have  	have  	 VB	O
the  	the  	 DT	O
potential  	potential  	 JJ	O
to  	to  	 TO	O
differentiate  	differentiate  	 VB	O
into  	into  	 IN	O
any  	any  	 DT	O
cell  	cell  	 NN	O
types  	types  	 NNS	O
in  	in  	 IN	O
the  	the  	 DT	O
body 	body 	 NN	O
.  	.  	 .	O
In  	In  	 IN	O
addition 	addition 	 NN	B-NP
,  	,  	 ,	O
they  	they  	 PRP	O
can  	can  	 MD	O
carry  	carry  	 VB	O
one  	one  	 CD	O
or  	or  	 CC	O
more  	more  	 RBR	O
mutations  	mutations  	 JJ	O
responsible  	responsible  	 JJ	O
for  	for  	 IN	O
the  	the  	 DT	O
disease  	disease  	 NN	O
of  	of  	 IN	O
interest  	interest  	 NN	O
or  	or  	 CC	O
be  	be  	 VB	O
genetically  	genetically  	 RB	O
corrected  	corrected  	 VBN	O
to  	to  	 TO	O
create  	create  	 VB	O
isogenic  	isogenic  	 JJ	B-NP
controls 	controls 	 NNS	I-NP
.  	.  	 .	O
Our  	Our  	 PRP$	O
work  	work  	 NN	O
has  	has  	 VBZ	O
focused  	focused  	 VBN	O
on  	on  	 IN	O
modeling  	modeling  	 FW	O
rare  	rare  	 FW	O
musculoskeletal  	musculoskeletal  	 FW	B-NP
disorders  	disorders  	 FW	I-NP
including  	including  	 FW	I-NP
fibrodysplasia  	fibrodysplasia  	 FW	I-NP
ossificans  	ossificans  	 FW	I-NP
progressive  	progressive  	 FW	O
( 	( 	 -LRB-	O
FOP 	FOP 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
a  	a  	 DT	O
congenital  	congenital  	 JJ	B-NP
disease  	disease  	 NN	I-NP
of  	of  	 IN	O
increased  	increased  	 JJ	O
heterotopic  	heterotopic  	 JJ	B-NP
ossification 	ossification 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
this  	this  	 DT	O
review 	review 	 NN	O
,  	,  	 ,	O
we  	we  	 PRP	O
will  	will  	 MD	O
discuss  	discuss  	 VB	O
our  	our  	 PRP$	O
experiences  	experiences  	 NNS	O
and  	and  	 CC	O
protocols  	protocols  	 NNS	O
differentiating  	differentiating  	 VBG	O
human  	human  	 JJ	O
iPS  	iPS  	 JJ	B-NP
cells  	cells  	 NNS	I-NP
toward  	toward  	 IN	O
the  	the  	 DT	O
osteogenic  	osteogenic  	 JJ	B-NP
lineage  	lineage  	 NN	I-NP
and  	and  	 CC	O
their  	their  	 PRP$	O
application  	application  	 NN	O
to  	to  	 TO	O
model  	model  	 VB	O
skeletal  	skeletal  	 JJ	B-NP
diseases 	diseases 	 NNS	I-NP
.  	.  	 .	O
A  	A  	 DT	O
number  	number  	 NN	O
of  	of  	 IN	O
critical  	critical  	 JJ	B-NP
challenges  	challenges  	 NNS	I-NP
and  	and  	 CC	O
exciting  	exciting  	 JJ	O
new  	new  	 JJ	O
approaches  	approaches  	 NNS	O
are  	are  	 VBP	O
also  	also  	 RB	O
discussed 	discussed 	 VBN	O
,  	,  	 ,	O
which  	which  	 WDT	O
will  	will  	 MD	O
allow  	allow  	 VB	O
the  	the  	 DT	O
skeletal  	skeletal  	 JJ	B-NP
biology  	biology  	 NN	I-NP
field  	field  	 NN	I-NP
to  	to  	 TO	O
harness  	harness  	 VB	O
the  	the  	 DT	O
potential  	potential  	 NN	O
of  	of  	 IN	O
human  	human  	 JJ	O
iPS  	iPS  	 JJ	B-NP
cells  	cells  	 NNS	I-NP
as  	as  	 IN	O
a  	a  	 DT	O
critical  	critical  	 JJ	B-NP
model  	model  	 NN	I-NP
system  	system  	 NN	I-NP
for  	for  	 IN	I-NP
understanding  	understanding  	 VBG	I-NP
diseases  	diseases  	 NNS	I-NP
of  	of  	 IN	O
abnormal  	abnormal  	 JJ	O
skeletal  	skeletal  	 JJ	B-NP
formation  	formation  	 NN	I-NP
and  	and  	 CC	O
bone  	bone  	 NN	O
regeneration 	regeneration 	 NN	O
.  	.  	 .	O
